Phase II Study of Pentostatin With Cyclophosphamide and Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Pentostatin (Primary) ; Cyclophosphamide; Rituximab
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 08 Jan 2016 Status changed from suspended to completed, as reported by ClinicalTrials.gov.
- 05 Mar 2015 Planned End Date changed from 1 May 2014 to 1 May 2016 as reported by ClinicalTrials.gov record.
- 05 Mar 2015 Planned primary completion date changed from 1 May 2014 to 1 May 2016 as reported by ClinicalTrials.gov record.